Novartis is proud of its collaborations. Working together with the NHS, its staff and patient groups is vital for improving outcomes for patients and ensuring they receive the best possible care. Patients benefit from these collaborations with new and improved medicines, better services and care, and clinical teams that have benefited from education.

Novartis fully participates in the Association of British Pharmaceutical Industry’s (ABPI) Disclosure UK initiative to increase transparency about the relationships we have with doctors, nurses, pharmacists and other healthcare professionals.

Transparency across the public sector, including healthcare, is increasingly being demanded by the general public. Novartis makes every effort to encourage all individuals to disclose details of their payments and is committed to continuing working with all stakeholders to increase transparency around these relationships.

We believe that open communication about these interactions helps foster trust with patients, the NHS and the public. We aspire to remain a trusted leader in changing the practice of medicine. We abide by the highest ethical standards and laws in the UK, including those around business integrity, anti-bribery and anti-corruption, marketing practices and data privacy.

UK | May 2024 | 289151-1